[Murine models of platelet diseases].

Area of Science:

• Hematology
• Genetics
• Molecular Biology

Context:

• Platelet-related diseases involve hereditary or immunological functional defects or production abnormalities.
• Mouse genome manipulation (transgenesis, gene inactivation) has yielded strains with defective platelet function or production.
• These models replicate known human hemostatic disorders and thrombopoiesis defects.

Purpose:

• To model hereditary platelet diseases like Glanzmann thrombasthenia and Bernard-Soulier syndrome (BSS).
• To investigate the roles of platelet receptors and signaling proteins in hemostasis and thrombosis.
• To elucidate poorly understood thrombopoiesis mechanisms involving transcription factors, growth factors, and cytoskeletal proteins.

Summary:

• Mouse models with spontaneous mutations affecting platelet granules serve as models for storage pool diseases (SPDs), including Gray platelet syndrome (alphaSPD) and Hermansky-Pudlack syndrome (deltaSPD).
• Systematic chemical mutagenesis has identified novel genes crucial for thrombopoiesis and platelet survival.
• Developed mouse models of immune thrombocytopenia aid in studying platelet destruction and removal processes.

Impact:

• These mouse models are invaluable for studying platelet function, hemostasis, thrombosis, and thrombopoiesis.
• They provide insights into the mechanisms underlying various platelet disorders, including storage pool diseases and immune thrombocytopenias.
• Advancements in mouse genetics facilitate the creation of sophisticated models for a wide range of hematological research.